Trial Profile
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 28 Mar 2018 Status changed from active, no longer recruiting to completed.
- 11 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
- 08 Jan 2018 Results published in the Aclaris Therapeutics media release.